{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:59:12Z","timestamp":1762459152619},"reference-count":44,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/j.biopsych.2014.01.019","type":"journal-article","created":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T16:15:25Z","timestamp":1391271325000},"page":"704-710","source":"Crossref","is-referenced-by-count":15,"title":["Small Vessel Disease, but Neither Amyloid Load nor Metabolic Deficit, Is Dependent on Age at Onset in Alzheimer\u2019s Disease"],"prefix":"10.1016","volume":"77","author":[{"given":"Marion","family":"Ortner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Kurz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiotis","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Auer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janine","family":"Diehl-Schmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Drzezga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"F\u00f6rster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"F\u00f6rstl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Perneczky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Sorg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Behrooz H.","family":"Yousefi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timo","family":"Grimmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2014.01.019_bib1","first-page":"1129","article-title":"\u00dcber einen eigenartigen schweren Erkrankungsproze\u00df der Hirnrinde","author":"Alzheimer","year":"1906","journal-title":"Neurologisches Centralblatt"},{"key":"10.1016\/j.biopsych.2014.01.019_bib2","first-page":"146","article-title":"\u00dcber eine eigenartige Erkrankung der Hirnrinde","author":"Alzheimer","year":"1907","journal-title":"Allgemeine Zeitschrift f\u00fcr Psychiatrie und Pschisch-Gerichtliche Medizin"},{"key":"10.1016\/j.biopsych.2014.01.019_bib3","series-title":"Psychiatrie: Ein Lehrbuch f\u00fcr Studierende und \u00c4rzte. II. Band Klinische Psychiatrie. 1. Teil","author":"Kraepelin","year":"1910"},{"key":"10.1016\/j.biopsych.2014.01.019_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/archneur.1976.00500040001001","article-title":"The prevalence and malignancy of Alzheimer disease. A major killer","volume":"33","author":"Katzman","year":"1976","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2014.01.019_bib5","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(83)91462-9","article-title":"Neuronal counts in basal nucleus of Meynert in Alzheimer disease and in simple senile dementia","volume":"1","author":"Tagliavini","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2014.01.019_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1046\/j.1365-2990.2002.00385.x","article-title":"Synapse loss is greater in presenile than senile onset Alzheimer disease: Implications for the cognitive reserve hypothesis","volume":"28","author":"Bigio","year":"2002","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.biopsych.2014.01.019_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0197-4580(92)90015-P","article-title":"Differences of regional cerebral glucose metabolism between presenile and senile dementia of Alzheimer type","volume":"13","author":"Mielke","year":"1992","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2014.01.019_bib8","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1093\/brain\/awh539","article-title":"Glucose metabolism in early onset versus late onset Alzheimer\u2019s disease: An SPM analysis of 120 patients","volume":"128","author":"Kim","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2014.01.019_bib9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/brain\/awp326","article-title":"Increased metabolic vulnerability in early-onset Alzheimer\u2019s disease is not related to amyloid burden","volume":"133","author":"Rabinovici","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2014.01.019_bib10","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/JGP.0b013e318202bf3a","article-title":"Relationship of amyloid-beta burden with age-at-onset in Alzheimer disease","volume":"19","author":"Choo","year":"2011","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2014.01.019_bib11","doi-asserted-by":"crossref","first-page":"10625","DOI":"10.1073\/pnas.91.22.10625","article-title":"Glutamate uptake into astrocytes stimulates aerobic glycolysis: A mechanism coupling neuronal activity to glucose utilization","volume":"91","author":"Pellerin","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2014.01.019_bib12","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer\u2019s disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.biopsych.2014.01.019_bib13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1212\/WNL.46.1.136","article-title":"Clinical and neuropsychological differences between patients with earlier and later onset of Alzheimer\u2019s disease: A CERAD analysis, Part XII","volume":"46","author":"Koss","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.01.019_bib14","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3233\/JAD-2012-111934","article-title":"Early onset Alzheimer\u2019s disease is associated with a distinct neuropsychological profile","volume":"30","author":"Smits","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2014.01.019_bib15","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1093\/brain\/aws113","article-title":"Amyloid burden and metabolic function in early-onset Alzheimer\u2019s disease: Parietal lobe involvement","volume":"135","author":"Ossenkoppele","year":"2012","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2014.01.019_bib16","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.neurobiolaging.2008.01.016","article-title":"Clinical severity of Alzheimer\u2019s disease is associated with PIB uptake in PET","volume":"30","author":"Grimmer","year":"2009","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2014.01.019_bib17","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00415-005-0551-3","article-title":"Cerebral metabolic correlates of four dementia scales in Alzheimer\u2019s disease","volume":"252","author":"Salmon","year":"2005","journal-title":"J Neurol"},{"key":"10.1016\/j.biopsych.2014.01.019_bib18","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/01.JGP.0000192478.82189.a8","article-title":"Mapping scores onto stages: Mini-mental state examination and clinical dementia rating","volume":"14","author":"Perneczky","year":"2006","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.biopsych.2014.01.019_bib19","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1212\/WNL.0b013e3181a2e8d0","article-title":"Effect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease","volume":"72","author":"Drzezga","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.01.019_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/01.WNL.0000148478.39691.D3","article-title":"Cerebral glucose metabolism in patients with AD and different APOE genotypes","volume":"64","author":"Drzezga","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.01.019_bib21","doi-asserted-by":"crossref","first-page":"e1000180","DOI":"10.1371\/journal.pmed.1000180","article-title":"Epidemiological pathology of dementia: Attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study","volume":"6","author":"Matthews","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.biopsych.2014.01.019_bib22","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.12.010","article-title":"Age-related changes in white matter lesions, hippocampal atrophy, and cerebral microbleeds in healthy subjects without major cerebrovascular risk factors","volume":"20","author":"Chowdhury","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.biopsych.2014.01.019_bib23","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000285518","article-title":"Prevalence and impact of cerebrovascular lesions in Alzheimer and lewy body diseases","volume":"7","author":"Jellinger","year":"2010","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.biopsych.2014.01.019_bib24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jama.1997.03540340047031","article-title":"Brain infarction and the clinical expression of Alzheimer disease. The Nun Study","volume":"277","author":"Snowdon","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.biopsych.2014.01.019_bib25","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: From pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2014.01.019_bib26","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1001\/archneur.61.10.1531","article-title":"Cerebral white matter lesions and the risk of dementia","volume":"61","author":"Prins","year":"2004","journal-title":"Arch Neurol"},{"issue":"pt 3","key":"10.1016\/j.biopsych.2014.01.019_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1093\/brain\/115.3.735","article-title":"White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer\u2019s disease. Evidence for heterogeneity","volume":"115","author":"Scheltens","year":"1992","journal-title":"Brain"},{"key":"10.1016\/j.biopsych.2014.01.019_bib28","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.neurobiolaging.2012.01.016","article-title":"White matter hyperintensities predict amyloid increase in Alzheimer\u2019s disease","volume":"33","author":"Grimmer","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2014.01.019_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state.\u201d A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.biopsych.2014.01.019_bib30","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1212\/WNL.39.9.1159","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer\u2019s disease","volume":"39","author":"Morris","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.01.019_bib31","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1212\/WNL.48.6.1508","article-title":"Clinical dementia rating training and reliability in multicenter studies: The Alzheimer\u2019s Disease Cooperative Study experience","volume":"48","author":"Morris","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.01.019_bib32","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.01.019_bib33","first-page":"1920","article-title":"FDG PET imaging in patients with pathologically verified dementia","volume":"41","author":"Hoffman","year":"2000","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2014.01.019_bib34","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/01.wnl.0000269790.05105.16","article-title":"What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia?","volume":"69","author":"Jagust","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.01.019_bib35","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.biopsych.2014.01.019_bib36","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/WNL.43.2.250","article-title":"Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop","volume":"43","author":"Roman","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.biopsych.2014.01.019_bib37","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1093\/clinchem\/43.9.1657","article-title":"Improved method for genotyping apolipoprotein E polymorphisms by a PCR-based assay simultaneously utilizing two distinct restriction enzymes","volume":"43","author":"Zivelin","year":"1997","journal-title":"Clin Chem"},{"key":"10.1016\/j.biopsych.2014.01.019_bib38","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1159\/000077732","article-title":"Region-specific decline of cerebral glucose metabolism in patients with frontotemporal dementia: A prospective 18F-FDG-PET study","volume":"18","author":"Grimmer","year":"2004","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/j.biopsych.2014.01.019_bib39","first-page":"1959","article-title":"Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: A comparative analysis","volume":"46","author":"Lopresti","year":"2005","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2014.01.019_bib40","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0022-510X(93)90041-V","article-title":"A semiquantative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging","volume":"114","author":"Scheltens","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.biopsych.2014.01.019_bib41","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biopsych.2010.05.013","article-title":"Progression of cerebral amyloid load is associated with the apolipoprotein E epsilon4 genotype in Alzheimer\u2019s disease","volume":"68","author":"Grimmer","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2014.01.019_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1006\/nimg.2001.0978","article-title":"Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain","volume":"15","author":"Tzourio-Mazoyer","year":"2002","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2014.01.019_bib43","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1162\/153535003322556877","article-title":"AMIDE: A free software tool for multimodality medical image analysis","volume":"2","author":"Loening","year":"2003","journal-title":"Mol Imaging"},{"key":"10.1016\/j.biopsych.2014.01.019_bib44","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/jcbfm.1995.45","article-title":"II. Statistical parametric mapping: Ontology and current issues","volume":"15","author":"Friston","year":"1995","journal-title":"J Cereb Blood Flow Metab"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322314000584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322314000584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T00:00:58Z","timestamp":1597449658000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322314000584"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S0006322314000584"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2014.01.019","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2015,4]]}}}